Special Series (Part 3 of 3) Up the Line to Goodna: Patient rights and staff fights

As old as the state of Queensland itself, Goodna Mental Hospital became Australia's largest asylum, housing 50,000 people over its lifetime

Pa. diocese sued after abuse accuser's suicide

The estate of a man allegedly abused by a priest in the 1980s is suing the Roman Catholic Diocese of Pittsburgh, alleging he committed suicide this year after the diocese stopped paying for his mental health treatments after two other suicide attempts.

APNewsBreak: Pa. diocese sued in accuser's suicide

The estate of a man allegedly abused by a priest in the 1980s is suing the Roman Catholic Diocese of Pittsburgh, alleging he committed suicide this year after the diocese stopped paying for his mental health treatments following two other suicide attempts.

Well and Good

Candwich is the perfect product for people on the go, such as students, construction workers, soccer moms and outdoor enthusiasts. Candwich has a long shelf life that is perfect for emergency food storage needs in the event of natural disasters. Ann Carey Tobin, MD, says ancient cultures knew of mushrooms' health value, and now modern science is cathing up. Medicinal mushroom proponents feel ...

Bed Bugs Affect Mental Health, Confirms City

"Bed bugs are a pest like no other," according 39-page report the city issued today. Bed bugs (as we have long believed) affect our very brains: The effects of bed bugs on human health can be significant, despite the fact that bed bugs have never been shown to spread disease. . . .  The most significant health effects appear to be the onset of stress, anxiety, depression, and fatigue caused by ...

Mental Health Center Aims To Help Fishermen

One group is doing what it can to help fishermen and others suffering from stress and health effects because of the Gulf oil spill.

Intra-Cellular Therapies Announces The Successful Completion Of A Phase Ib/II Study Of ITI-007 In Patients With ...

Intra-Cellular Therapies, Inc. announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia. In addition, several exploratory endpoints were ...